ACADIA Pharmaceuticals Inc.ACADNASDAQ

Revenue (LTM)

$1.1B

+11.9% YoY

Net Income (LTM)

$391M

+72.7% YoY

Free Cash Flow

$105M

Revenue CAGR (5Y)

+22.0%

Marginsdeclining

FCF$0.1B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	484	517↑6.8%	726↑40.4%	958↑31.8%	1,072↑11.9%
Gross Profit	465	507↑9.0%	681↑34.2%	876↑28.7%	983↑12.2%
Operating Income	-170	-224↓31.2%	-73↑67.2%	231↑414.5%	105↓54.6%
Net Income	-168	-216↓28.7%	-61↑71.6%	226↑469.5%	391↑72.7%
EBITDA	-167	-222↓32.6%	-68↑69.4%	100↑247.7%	139↑38.7%
EPS Diluted	-1.05	-1.34↓27.6%	-0.37↑72.4%	1.36↑467.6%	2.29↑68.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	147	115↓22.1%	189↑64.3%	320↑69.4%	178↓44.4%
Total Current Assets	618	508↓17.8%	616↑21.3%	938↑52.3%	1,062↑13.2%
Total Assets	700	588↓16.0%	749↑27.4%	1,188↑58.6%	1,564↑31.7%
Total Current Liabilities	96	126↑30.8%	254↑102.4%	395↑55.3%	277↓29.8%
Total Liabilities	159	187↑17.7%	317↑69.3%	455↑43.4%	337↓26.0%
Total Equity	541	400↓26.0%	432↑7.8%	733↑69.7%	1,227↑67.5%
Total Debt	64	62↓3.8%	57↓7.7%	52↓9.1%	52↑0.4%
Net Debt	-83	-53↑36.3%	-131↓148.7%	-268↓103.6%	-126↑53.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-126	-114↑9.3%	17↑114.6%	158↑844.3%	110↓30.4%
Capital Expenditure	-1	0	-40	-1↑98.7%	-5↓796.7%
Free Cash Flow	-127	-114↑10.1%	-23↑79.5%	157↑773.3%	105↓33.1%
Stock-Based Comp	64	68↑7.2%	66↓2.6%	67↑0.9%	0
Net Change in Cash	-179	-33↑81.8%	74↑326.5%	134↑81.5%	-142↓205.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance